PolyPid: Funding, Investors & Team (Sep 2026)
PolyPid is a company in the development stage that has created a platform technology for the healthcare sector. This technology allows for a controlled and extended release of active pharmaceutical ingredients. By combining polymers and lipids, PolyPid can trap small and large APIs in protective environments, allowing for their release at predetermined rates for several months. This flexible technology can be used for various therapeutic applications.
PolyPid has raised $23.1M across 2 funding rounds on record, the most recent an undisclosed round of $8.1M announced in Aug 2024.
That round is in line with the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
PolyPid Company Profile and Key Stats
Latest funding round on record: Aug 2024.
PolyPid Funding Rounds
PolyPid raised $15.0M in a Post-IPO Debt announced in Apr 2022.
2.3 years later, an undisclosed round of $8.1M was announced in Aug 2024.
PolyPid Founders and Leadership Team
Contact details for the PolyPid team: 1 of 1 has an email address on file.
Start 14-day free trial →PolyPid Funding Compared to Other Biotechnology Startups
PolyPid's latest round of $8.1M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PolyPid in Biotechnology and Petah Tiqva
Companies Similar to PolyPid
CollPlant is a regenerative medicine company that focuses on 3D bioprinting of tissues and organs and also…
Magdent’s novel technology utilizes electromagnetic fields, PEMF technology, to stimulate, accelerate, and…
Brevel has created an innovative method of cultivating microalgae that is both sustainable and…
RedHill Biopharma Ltd. (NASDAQ: RDHL) is a specialty biopharmaceutical company primarily focused on…
Regentis Biomaterials is a privately held company focused on developing and commercializing proprietary…
IceCure Medical is a medical device company setting new standards in minimally-invasive tumor therapy for…
Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing…
Phytolon is transforming the process of creating food colors by using an innovative and environmentally…
BlueWind Medical develops and markets a wireless neurostimulation device for the treatment of peripheral…
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
ECOncrete technology provides sustainable solutions for construction of ecologically active infrastructures,…
MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for…
PolyPid Funding FAQs
What does PolyPid do?
PolyPid is a company in the development stage that has created a platform technology for the healthcare sector. This technology allows for a controlled and extended release of active pharmaceutical ingredients. By combining polymers and lipids, PolyPid can trap small and large APIs in protective environments, allowing for their release at predetermined rates for several months. This flexible technology can be used for various therapeutic applications.
How much funding has PolyPid raised?
PolyPid has raised $23.1M across 2 rounds on record. The most recent is an undisclosed round of $8.1M announced in Aug 2024.
When did PolyPid last raise funding?
PolyPid's most recent funding round on record is an undisclosed round of $8.1M, announced in Aug 2024.
Who founded PolyPid?
FundedIQ lists Amir Weisberg (Founder) at PolyPid.
Where is PolyPid headquartered?
PolyPid is based in Petah Tiqva, Hamerkaz, Israel.
How many employees does PolyPid have?
PolyPid is in the 51-100 employee band.
How does PolyPid's funding compare to other Biotechnology startups?
PolyPid's latest round of $8.1M is in line with the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's PolyPid Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PolyPid is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.